Detection of Celiac Disease in Primary Care: A Multicenter Case-Finding Study in North America

Catassi, Carlo; Kryszak, Deborah; Louis-Jacques, Otto; Duerksen, Donald R.; Hill, Ivor; Crowe, Sheila E.; Brown, Andrew R.; Procaccini, Nicholas J.; Wonderly, Brigid A.; Hartley, Paul; Moreci, James; Bennett, Nathan; Horvath, Karoly; Burk, Margaret; Fasano, Alessio
July 2007
American Journal of Gastroenterology;Jul2007, Vol. 102 Issue 7, p1454
Academic Journal
BACKGROUND: Celiac disease (CD) is one of the most common lifelong disorders in western countries. However, most cases remain currently undiagnosed in North America, mostly due to poor awareness of CD by primary care physicians. OBJECTIVES: The aims of this study were (a) to determine whether an active case-finding strategy in primary care could increase the frequency of CD diagnosis and (b) to determine the most common clinical presentations of the condition. METHODS:This was a multicenter, prospective study involving adult subjects during the years 2002–2004, attending one of the participating practices. All individuals with symptoms or conditions known to be associated with CD were tested for immunoglobulin A anti-transglutaminase (tTG) antibodies, and those with elevated anti-tTG were subsequently tested for IgA antiendomysial antibodies (EMA). All subjects who were positive for EMA were advised to undergo an intestinal biopsy and HLA typing. RESULTS: The study group included 737 women and 239 men, with a median age of 54.3 yr. A positive anti-tTG test was found in 30 out of 976 investigated subjects (3.07%, 95% CI 1.98–4.16). CD was diagnosed in 22 patients (18 women, 4 men). The most frequent reasons for CD screening in these 22 cases were bloating (12/22), thyroid disease (11/22), irritable bowel syndrome (7/22), unexplained chronic diarrhea (6/22), chronic fatigue (5/22), and constipation (4/22). The prevalence of CD in the serologically screened sample was 2.25% (95% CI 1.32–3.18). The diagnostic rate was low at baseline (0.27 cases per thousand visits, 95% CI 0.13–0.41) and significantly increased to 11.6 per thousand visits (95% CI 6.8–16.4, P < 0.001) following active screening implementation. CONCLUSIONS: This study demonstrates that an active case-finding strategy in the primary care setting is an effective means to improve the diagnostic rate of CD in North America.


Related Articles

  • Fast Gene Test Kit Studied.  // GIG Newsletter;Winter2008, Vol. 31 Issue 1, p9 

    The article discusses research on the efficacy of a genetic typing kit in determining human lymphocyte antigen (HLA)-DQ2 and/or HLA-DQ8 in celiac disease patients. It references a study published in the 2008 issue of "Clinical Chemistry and Laboratory Medicine." According to the study, patients...

  • Mass screening for coeliac disease using antihuman transgulutaminase antibody assay. Tommasini, A.; Not, T.; Kiren, V.; Baldas, V.; Santon, D.; Trevisiol, C.; Berti, I.; Neri, E.; Gerarduzzi, T.; Bruno, I.; Lenhardt, A.; Zamuner, E.; Spanà, A.; Crovella, S.; Martellossi, S.; Torre, G.; Sblattero, D.; Marzari, R.; Bradbury, A.; Tamburlini, G. // Archives of Disease in Childhood;Jun2004, Vol. 89 Issue 6, p512 

    Aims: To determine coeliac disease prevalence by an anti-transglutaminase antibody assay in a large paediatric population; to evaluate acceptance of the screening programme, dietary compliance, and long term health effects. Methods: Cross-sectional survey of 3188 schoolchildren (aged 6-12) and...

  • Role of IgA and IgA Fc Receptors in Inflammation. Monteiro, Renato C. // Journal of Clinical Immunology;Jan2010, Vol. 30 Issue 1, p1 

    Signals delivered by serum monomeric IgA (mIgA) are essential in controlling the immune system by preventing the development of autoimmunity and inflammation. However, IgA can also, when aggregated, be deleterious to the host, inducing inflammatory diseases. This Janus-like nature of IgA is...

  • Lack of Serologic Evidence to Link IgA Nephropathy with Celiac Disease or Immune Reactivity to Gluten. Moeller, Sina; Canetta, Pietro A.; Taylor, Annette K.; Arguelles-Grande, Carolina; Snyder, Holly; Green, Peter H.; Kiryluk, Krzysztof; Alaedini, Armin // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1 

    IgA nephropathy is the most common form of primary glomerulonephritis worldwide. Mucosal infections and food antigens, including wheat gluten, have been proposed as potential contributing environmental factors. Increased immune reactivity to gluten and/or association with celiac disease, an...

  • Independent Nurse: Report suggests adding dyspepsia and coeliac disease to QOF targets. Sands, Judy // GP: General Practitioner;3/24/2006, p68 

    This article focuses on the report "Care of Patients With Gastrointestinal Disorders in the United Kingdom: A Strategy for the Future," published by the British Society of Gastroenterology (BSG). Dyspepsia and coeliac disease should be included in the next round of changes to the quality and...

  • Resource Use and Costs Associated with Coeliac Disease before and after Diagnosis in 3,646 Cases: Results of a UK Primary Care Database Analysis. Violato, Mara; Gray, Alastair; Papanicolas, Irini; Ouellet, Melissa // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    Background: Despite the considerable health impact of coeliac disease (CD), reliable estimates of the impact of diagnosis on health care use and costs are lacking. Aims: To quantify the volume, type and costs, in a United Kingdom primary care setting, of healthcare resources used by individuals...

  • Intestinal Permeability and Antigliadin Antibody Test for Monitoring Adult Patients with Celiac Disease. Eduardo Vilela; Maria de Abreu Ferrari; Henrique de Gama Torres; Fabiana Martins; Eugênio Goulart; Agnaldo Lima; Aloíso da Cunha // Digestive Diseases & Sciences;May2007, Vol. 52 Issue 5, p1304 

    Abstract  Celiac disease causes chronic inflammation of the intestinal mucosa and reduces surface absorption; after the withdrawal of gluten from the diet, there are clinical and histologic improvements. The intestinal permeability test and serologic tests are useful for confirming the...

  • In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Korponay-Szabó, I. R.; Halttunen, I.; Szalai, Z.; Laurila, K.; Király, R.; Kovács, J. B.; Fésüs, L.; Möki, M. // Gut;May2004, Vol. 53 Issue 5, p641 

    Background: IgA class serum autoantibodies against type 2 (tissue) transglutaminase (TG2) bind to both intestinal and extraintestinal normal tissue sections in vitro, eliciting endomysial, reticulin, and jelunal antibody reactions. It is not known whether similar binding also occurs in coeliac...

  • Cost-effective strategy for the serological investigation of coeliac disease. Bowron, A.; Moorghen, M.; Morgan, J. E.; Osborne, J. R.; Stansbie, D.; Stone, J. E. // Annals of Clinical Biochemistry;Jul2000, Vol. 37 Issue 4, p467 

    Increased numbers of requests for serological investigation of coeliac disease, and a local trend to request both anti-gliadin antibodies (AGA) and antiendomysium antibodies (AEA) simultaneously, resulted in cost pressures that prompted a review of our practice. Serology results from all...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics